Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Current Deferred Tax Assets (2016)

Historic Current Deferred Tax Assets for Utah Medical Products (UTMD) over the last 7 years, with Q4 2016 value amounting to $393000.0.

  • Utah Medical Products' Current Deferred Tax Assets rose 826.45% to $393000.0 in Q4 2016 from the same period last year, while for Dec 2016 it was $393000.0, marking a year-over-year increase of 826.45%. This contributed to the annual value of $393000.0 for FY2016, which is 826.45% up from last year.
  • According to the latest figures from Q4 2016, Utah Medical Products' Current Deferred Tax Assets is $393000.0, which was up 826.45% from $363000.0 recorded in Q4 2015.
  • Utah Medical Products' 5-year Current Deferred Tax Assets high stood at $451000.0 for Q4 2012, and its period low was $303000.0 during Q4 2014.
  • In the last 5 years, Utah Medical Products' Current Deferred Tax Assets had a median value of $363000.0 in 2015 and averaged $367600.0.
  • In the last 5 years, Utah Medical Products' Current Deferred Tax Assets skyrocketed by 3543.54% in 2012 and then crashed by 2727.27% in 2013.
  • Utah Medical Products' Current Deferred Tax Assets (Quarter) stood at $451000.0 in 2012, then fell by 27.27% to $328000.0 in 2013, then fell by 7.62% to $303000.0 in 2014, then grew by 19.8% to $363000.0 in 2015, then increased by 8.26% to $393000.0 in 2016.
  • Its Current Deferred Tax Assets stands at $393000.0 for Q4 2016, versus $363000.0 for Q4 2015 and $303000.0 for Q4 2014.